Europe Cartilage Degeneration Market to Grow at a CAGR of 4.1% to reach US$ 3,365.09 Million from 2020 to 2027

Europe Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others); and End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Country

  • Report Code : TIPRE00014168
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 110
Buy Now

The Europe cartilage degeneration market is expected to reach US$ 3,365.09 million by 2027 from US$ 2,463.16 million in 2019; it is estimated to grow at a CAGR of 4.1% from 2020 to 2027.

The increasing prevalence of sports injuries and obesity is driving the growth of cartilage degeneration market in the region. However, the high cost of cartilage therapies and lack of reimbursement scenario are the major factors hindering the market growth in Europe.

Degeneration of cartilage can lead to pain and chronic inflammation in joints of the human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

According to a study published by British Journal of Sports Medicine, an estimated 3.1% of adults in Germany suffer from a sports injury, with an annual injury rate of 5.6%, ranking sports injuries as the second most common type of accident. Further, most common injuries observed among children and teenagers are sprains and strains. Dislocations, distortions, and/or torn ligaments make up 60% of all sports injuries, followed by fractures (18%), contusions, surface wounds, or open wounds (12%). An increasing number of incidents of sports injuries among players and athletes is anticipated to drive the growth of the cartilage degeneration market during the forecast period.

Additionally, European Home and Leisure Accidents Surveillance System (EHLASS), and official German statistics indicate that fatal sports accidents throughout the European Union (EU) and Germany account for only 1% of all fatalities. Also, two-thirds of the injuries are reported in soccer, handball, basketball, and volleyball. The growing number of participants in sports leads to increasing possibilities of sports injuries. Therefore, the rising prevalence of cartilage injuries will eventually accelerate the growth of the cartilage degeneration market in Europe by 2027.

The European economy is severely affected due to the exponential rise in the COVID-19 cases. The Medical Device Regulation (MDR) requires manufacturers to conduct Post Market Clinical Follow-Up (PMCF) studies to demonstrate the continued safety and performance of their devices. This is expected to impact the product launch and ongoing clinical trials of medical devices, thereby hampering the sales and the market growth. Also, disrupted supply chains, extended lockdowns, and canceling of other medical procedures have adversely affected the growth of the cartilage degeneration market in Europe.

Rest of Europe Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Mn)

Rest of Europe Cartilage Degeneration Market, Revenue and Forecast to 2027 (US$ Mn)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

EUROPE CARTILAGE DEGENERATION MARKET SEGMENTATION

By Procedure Type

  • Joint Replacement
  • Chondroplasty
  • Cell-based Cartilage Resurfacing
  • Osteochondral Transplant
  • Meniscus Transplants
  • Others

By Application

  • Knee
  • Hips
  • Other

By End User

  • Hospitals and Specialty Clinics
  • Ambulatory Surgical Centers
  • Academic and Research Institutes

By Country

  • Germany
  • UK
  • France
  • Italy
  • Spain

Company Profiles

  • B. Braun Melsungen AG
  • Smith & Nephew
  • Stryker Corporation
  • CartiHeal, Inc
  • Vericel Corporation
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Procedure Type, Application, and End User and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

UK, Germany, France, Italy, Russia

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Cartilage Degeneration Market – By Procedure Type

1.3.2 Europe Cartilage Degeneration Market – By Application

1.3.3 Europe Cartilage Degeneration Market– By End User

1.3.4 Europe Cartilage Degeneration Market – By Country

2. Europe Cartilage Degeneration Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Cartilage Degeneration Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Cartilage Degeneration Market - Europe PEST Analysis

4.3 Expert Opinion

5. Europe Cartilage Degeneration Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Growing Number of Sports Injuries

5.1.2 Increasing Prevalence of Obesity

5.2 Key Market Restraints

5.2.1 High Cost of Cartilage Repair Therapies

5.3 Key Market Opportunities

5.3.1 Growing Number of Product Approvals and Developments

5.4 Future Trends

5.4.1 Rising Emphasis on Regenerative Medicines

5.5 Impact analysis

6. Cartilage Degeneration Market – Europe Analysis

6.1 Europe Cartilage Degeneration Market Revenue Forecasts and Analysis

7. Europe Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Procedure Type

7.1 Overview

7.2 Europe Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)

7.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)

7.3 Osteochondral Transplant

7.3.1 Overview

7.3.2 Europe Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Chondroplasty

7.4.1 Overview

7.4.2 Europe Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Joint Replacement

7.5.1 Overview

7.5.2 Europe Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)

7.6 Meniscus Transplants

7.6.1 Overview

7.6.2 Europe Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)

7.7 Cell-based Cartilage Resurfacing

7.7.1 Overview

7.7.2 Europe Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)

7.8 Other Procedures

7.8.1 Overview

7.8.2 Europe Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)

8. Europe Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Application

8.1 Overview

8.2 Europe Cartilage Degeneration Market, By Application 2019 & 2027 (%)

8.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3 Knee

8.3.1 Overview

8.3.2 Europe Knee Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Hip

8.4.1 Overview

8.4.2 Europe Hip Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Other Applications

8.5.1 Overview

8.5.2 Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Cartilage Degeneration Market Analysis – By End-User

9.1 Overview

9.2 Europe Cartilage Degeneration Market, By End-User 2019-2027 (%)

9.2.1 Europe Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

9.3 Hospitals and Specialty Centres

9.3.1 Overview

9.3.2 Europe Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Ambulatory Surgical Centres

9.4.1 Overview

9.4.2 Europe Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Europe Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

10. Cartilage degeneration Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1 Europe Cartilage degeneration Market Revenue and Forecasts To 2027

10.1.1 Overview

10.1.2 Europe: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.3 Europe: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.4 Europe: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.5 Europe: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

10.1.6 Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)

10.1.7 Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 Germany: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3 Germany: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.1.7.4 Germany: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

10.1.8 France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 France: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3 France: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.1.8.4 France: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

10.1.9 UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2 UK: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3 UK: Cartilage Degeneration Market, Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.4 UK: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

10.1.10 Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1 Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2 Italy: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.3 Italy: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.1.10.4 Italy: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

10.1.11 Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1 Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2 Spain: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.3 Spain: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)

10.1.11.4 Spain: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Europe Cartilage degeneration Market

11.1 Europe: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 B. Braun Melsungen AG

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Smith & Nephew

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Stryker Corporation

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 CartiHeal, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Vericel Corporation

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Cartilage Degeneration Market Revenue and Forecasts To 2027, By Procedure Type (US$ Mn)

Table 2. Europe Cartilage Degeneration Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3. Europe Cartilage Degeneration Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 4. Europe: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 5. Europe: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6. Europe: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 7. Germany: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 8. Germany: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).

Table 9. Germany: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 10. France: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 11. France: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).

Table 12. France: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 13. UK: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 14. UK: Cartilage Degeneration Market, Application – Revenue and Forecast to 2027 (USD Million)

Table 15. UK: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 16. Italy: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 17. Italy: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).

Table 18. Italy: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 19. Spain: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)

Table 20. Spain: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).

Table 21. Spain: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)

Table 22. Glossary of Terms, Cartilage Degeneration Market

LIST OF FIGURES

Figure 1. Cartilage Degeneration Market Segmentation

Figure 2. Europe Cartilage Degeneration Market Overview

Figure 3. Knee Segment Held Largest Share of Cartilage Degeneration Market

Figure 4. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Europe Cartilage Degeneration Market - Leading Country Markets (US$ Mn)

Figure 6. Cartilage Degeneration Market - Europe PEST Analysis

Figure 7. Cartilage Degeneration Market Impact Analysis of Driver and Restraints

Figure 8. Europe Cartilage Degeneration Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Europe Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)

Figure 10. Europe Osteochondral Transplant Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Europe Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Europe Joint Replacement Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. Europe Meniscus Transplants Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Europe Cell-based Cartilage Resurfacing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15. Europe Other Procedures Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. Europe Cartilage Degeneration Market, By Application 2019 & 2027 (%)

Figure 17. Europe Knee Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. Europe Hip Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Europe Cartilage Degeneration Market, by End-User 2019 & 2027 (%)

Figure 21. Europe Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. Europe Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. Europe Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Europe: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)

Figure 25. Europe: Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)

Figure 26. Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)

Figure 27. Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 28. France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 29. UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 31. Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in Europe Country Markets

The List of Companies - Europe Cartilage Degeneration Market

  1. B. Braun Melsungen AG
  2. Smith & Nephew
  3. Stryker Corporation
  4. CartiHeal, Inc
  5. Vericel Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe Cartilage Degeneration Market